Bei B. Zhang
Department of Metabolic Disorders
Merck Research Laboratories
Rahway
NJ 07065
USA
Name/email consistency: high
- AMPK: an emerging drug target for diabetes and the metabolic syndrome. Zhang, B.B., Zhou, G., Li, C. Cell Metab. (2009)
- New approaches in the treatment of type 2 diabetes. Zhang, B.B., Moller, D.E. Curr. Opin. Chem. Biol (2000)
- Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Zhang, B., Salituro, G., Szalkowski, D., Li, Z., Zhang, Y., Royo, I., Vilella, D., Díez, M.T., Pelaez, F., Ruby, C., Kendall, R.L., Mao, X., Griffin, P., Calaycay, J., Zierath, J.R., Heck, J.V., Smith, R.G., Moller, D.E. Science (1999)
- Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., Moller, D.E. J. Biol. Chem. (1996)
